ADNRX

American Beacon ARK Transformational Innovation Fund ADNRX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ADNRX LVOLX DSCVX MSCFX DNMDX NESIX FMPFX JOF SKSEX
6M 92.57 % 10.20 % 25.42 % 27.69 % 1.72 % 56.25 % 36.90 % 23.74 % 21.67 %
YTD 50.93 % 4.71 % 6.35 % 1.81 % 0.62 % 11.82 % 11.15 % 33.33 % 2.02 %
1Y 80.90 % -15.74 % 1.43 % -0.67 % -0.07 % 14.42 % 14.96 % 32.48 % -2.50 %
3Y 127.26 % 7.95 % 17.06 % 16.37 % -6.98 % 53.92 % 60.34 % 83.30 % 20.77 %
5Y 127.26 % -4.94 % 18.72 % 29.02 % -12.00 % 35.40 % 56.31 % 23.74 % -5.52 %
10Y 127.26 % 25.65 % 9.23 % 57.71 % -20.59 % 45.18 % 229.83 % -1.62 % -21.78 %
From the beginning 127.26 % 25.65 % 161.28 % 209.90 % -22.16 % 45.18 % 229.83 % -14.00 % 220.71 %

Dividend

American Beacon ARK Transformational Innovation Fund

SGI U.S. Large Equity Fund

BNY Mellon Opportunistic Small Cap Fund

Mairs & Power Small Cap Fund

Dunham Monthly Distribution Fund

Needham Small Cap Growth Fund

Nuveen Small Cap Growth Opportunities Fund

Japan Smaller Capitalization Fund, Inc.

AMG GW&K Small Cap Value Fund